Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
Pathology Outlines - HER2 (c-erbB2) breast
HER2 status in breast Cancer: What does it mean? - Moose and Doc
/diagnosis-and-testing-for-her2-positive-breast-cancer-4151804-53c6bdb1bb654ed69ce7f967626b7e4e.png "HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival")
HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival
NFk B drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Breast cancer: a new target? | Recherche animale
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Breast cancer: a new target? | Recherche animale
Clinical applications of mouse models for breast cancer engaging HER2/neu
Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity | Journal of Nanobiotechnology | Full Text
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway: Molecular Therapy
The landscape of d16HER2 splice variant expression across HER2-positive cancers | Scientific Reports
Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities | HTML
HER2 expression in primary breast cancer tissues. ( A ), Western blot... | Download Scientific Diagram
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology
Table 2 | TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy | SpringerLink
Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink
Biologicals to direct nanotherapeutics towards HER2-positive breast cancers - ScienceDirect
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram
Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
HER2/neu - Wikipedia
Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity | Journal of Nanobiotechnology | Full Text
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - EBioMedicine
Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO
